梅奥诊所对AUA局限期肾细胞癌风险分组的验证
该研究基于梅奥诊所肾切除登记库,纳入1980至2012年因单侧M0透明细胞或乳头状肾细胞癌接受根治或部分肾切除术的成人患者,评估AUA风险分组对无进展生存和癌症特异性生存的预测能力,并与本机构风险模型比较。结果显示AUA分组在透明细胞癌中C指数约0.78至0.81,乳头状癌中约0.78至0.83。
要点
- AUA风险分组在透明细胞癌中PFS的C指数为0.780,本机构模型为0.815,差异有统计学意义(P < .001)。
- AUA风险分组在透明细胞癌中CSS的C指数为0.811,本机构模型为0.857,差异有统计学意义(P < .001)。
- AUA分组在乳头状癌中PFS的C指数为0.775,本机构模型为0.751(P = .002);CSS的C指数分别为0.830和0.803(P = .2)。
核心结论
- AUA风险分组是一种简洁的肾细胞癌分类系统,在局限期透明细胞癌和乳头状癌术后对PFS和CSS的C指数约为0.80。
研究设计与样本
- 研究查询梅奥诊所肾切除登记库,纳入1980至2012年因单侧M0透明细胞或乳头状肾细胞癌接受根治或部分肾切除术的成人患者。
- AUA分层不适用于其他RCC亚型,因为其他RCC如嫌色细胞癌的肿瘤分级不常规进行。
- 采用Kaplan-Meier法估计PFS和CSS,采用Cox比例风险回归模型的C指数评估预测能力。
主要发现
- 共纳入3191例透明细胞RCC患者和633例乳头状RCC患者。
- 透明细胞RCC患者中,AUA风险分组与本机构模型的PFS C指数分别为0.780和0.815(P < .001)。
- 透明细胞RCC患者中,AUA风险分组与本机构模型的CSS C指数分别为0.811和0.857(P < .001)。
- 乳头状RCC患者中,AUA风险分组与本机构模型的PFS C指数分别为0.775和0.751(P = .002)。
- 乳头状RCC患者中,AUA风险分组与本机构模型的CSS C指数分别为0.830和0.803(P = .2)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The AUA guidelines introduced a new risk group stratification system based primarily on tumor stage and grade to guide surveillance for patients treated surgically for localized renal cell carcinoma (RCC). We sought to evaluate the predictive ability of these risk groups using progression-free survival (PFS) and cancer-specific survival (CSS), and to compare their performance to that of our published institutional risk models. MATERIALS AND METHODS: We queried our Nephrectomy Registry to identify adults treated with radical or partial nephrectomy for unilateral, M0, clear cell RCC, or papillary RCC from 1980 to 2012. The AUA stratification does not apply to other RCC subtypes as tumor grading for other RCC, such as chromophobe, is not routinely performed. PFS and CSS were estimated using the Kaplan-Meier method. Predictive abilities were evaluated using C indexes from Cox proportional hazards regression models. RESULTS: A total of 3191 patients with clear cell RCC and 633 patients with papillary RCC were included. For patients with clear cell RCC, C indexes for the AUA risk groups and our model were 0.780 and 0.815, respectively (P < .001) for PFS, and 0.811 and 0.857, respectively (P < .001), for CSS. For patients with papillary RCC, C indexes for the AUA risk groups and our model were 0.775 and 0.751, respectively (P = .002) for PFS, and 0.830 and 0.803, respectively (P = .2) for CSS. CONCLUSIONS: The AUA stratification is a parsimonious system for categorizing RCC that provides C indexes of about 0.80 for PFS and CSS following surgery for localized clear cell and papillary RCC.
引用
- Zganjar A, Khanna A, Joyce D, et al. Mayo Clinic Validation of the AUA Risk Groups for Localized Renal Cell Carcinoma. J Urol. 2024. PMID: 38813884. doi:10.1097/JU.0000000000004030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。